Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CEOUsman Azam
CEOUsman Azam
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap29.99M
Market cap29.99M
Price-Earnings ratio-0.71
Price-Earnings ratio-0.71
Dividend yield—
Dividend yield—
Average volume1.87M
Average volume1.87M
High today$0.34
High today$0.34
Low today$0.2381
Low today$0.2381
Open price$0.24
Open price$0.24
Volume7.19M
Volume7.19M
52 Week high$1.75
52 Week high$1.75
52 Week low$0.2302
52 Week low$0.2302
Stock Snapshot
Cue Biopharma(CUE) stock is priced at $0.31, giving the company a market capitalization of 29.99M. It carries a P/E multiple of -0.71.
As of 2025-12-28, Cue Biopharma(CUE) stock has fluctuated between $0.24 and $0.34. The current price stands at $0.31, placing the stock +28.9% above today's low and -9.7% off the high.
Cue Biopharma(CUE) shares are trading with a volume of 7.19M, against a daily average of 1.87M.
During the past year, Cue Biopharma(CUE) stock moved between $0.23 at its lowest and $1.75 at its peak.
During the past year, Cue Biopharma(CUE) stock moved between $0.23 at its lowest and $1.75 at its peak.
People also own
Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.